Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3)

Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3)

Bibliographic Details
Main Authors:	Chambers, J, Reed, N, Mansoor, W, Ross, P, Grossman, A
Format:	Conference item
Published:	2010

Similar Items

Adrenocortical Cancer: A Therapeutic Approach with Everolimus (RAD001)
by: Gueorguiev, M, et al.
Published: (2010)

Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study.
by: Fazio, N, et al.
Published: (2013)

Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
by: Druce, MR, et al.
Published: (2009)

Effect of Everolimus plus Octreotide LAR in Patients With Advanced Lung Neuroendocrine Tumours - Analysis From RADIANT-2
by: Fazio, N, et al.
Published: (2011)

The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
by: Grozinsky-Glasberg, S, et al.
Published: (2009)

The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
by: Grozinsky-Glasberg, S, et al.
Published: (2010)

Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
by: Grozinsky-Glasberg, S, et al.
Published: (2008)

Adjunctive Everolimus Therapy for Treatment-resistant Focal-onset Seizures Associated with Tuberous Sclerosis: A Phase 3, Randomised, Double-blind, Placebo-controlled Study
by: Mustafa Karaoğlan
Published: (2018-06-01)

Preliminary Report of the Use of Everolimus in a Patient with Progressive Medullary Thyroid Carcinoma
by: Druce, M, et al.
Published: (2010)

Everolimus therapy for progressive adrenocortical cancer.
by: Fraenkel, M, et al.
Published: (2013)

Everolimus therapy for progressive adrenocortical cancer
by: Fraenkel, M, et al.
Published: (2013)

IGF2-induced hypoglycemia unresponsive to everolimus.
by: Korevaar, T, et al.
Published: (2014)

Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.
by: Chan, H, et al.
Published: (2010)

Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters
by: Maria Ingenerf, et al.
Published: (2022-10-01)

Radiant angel /
by: DeMille, Nelson, John Corey novels, author
Published: (2016)

Radiant heating/
by: Adlam, Thomas Napier, 1882-
Published: (1949)

RADIANT SHADOWS /
by: 407724 Marr, Melissa
Published: (2010)

Elucidating the effects of radiant and sub-radiant interactions in terahertz metamaterials
by: Manjappa, Manukumara
Published: (2019)

P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study
by: S. Kümmel, et al.
Published: (2023-03-01)

Phase change temperature adjustment of CH3COONa·3H2O to fabricate composite phase change material for radiant floor heating
by: Wanwan Fu, et al.
Published: (2023-02-01)

EVEROLIMUS PLUS OCTREOTIDE LAR IN PATIENTS WITH LUNG CARCINOIDS
by: Granberg, D, et al.
Published: (2014)

RAD001 enhances the potency of BEZ235 to inhibit mTOR signaling and tumor growth.
by: Beat Nyfeler, et al.
Published: (2012-01-01)

Clinical Outcomes of Everolimus Rechallenge in Patients with Pancreatic Neuroendocrine Neoplasms with No Other Treatment Options
by: Yusuke Kurita, et al.
Published: (2022-11-01)

Prolonged Clinical Benefit of Everolimus Therapy in the Management of High-Grade Pancreatic Neuroendocrine Carcinoma
by: Paula J. Fonseca, et al.
Published: (2013-08-01)

The characteristics of radiant energy /
by: 312345 Feller, R. L.

CogRadNet: Ubiquitous heterogeneous wireless networks
by: Omar, Mohd Hasbullah, et al.
Published: (2009)

Radiant properties of materials : tables of radiant values for black body and real materials /
by: 462253 Sala, Aleksander
Published: (1986)

Hot on RAD51C: structure and functions of RAD51C‐XRCC3
by: Barnabas Szakal, et al.
Published: (2023-10-01)

Experimental and Numerical Study of the Radiant Induction-Unit and the Induction Radiant Air-Conditioning System
by: Qiang Si, et al.
Published: (2016-12-01)

Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma
by: Druce, M, et al.
Published: (2012)

Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma.
by: Druce, M, et al.
Published: (2012)

A Stable Micellar Formulation of RAD001 for Intracerebroventricular Delivery and the Treatment of Alzheimer’s Disease and Other Neurological Disorders
by: Laura Gianessi, et al.
Published: (2023-12-01)

Combination of everolimus with sorafenib for solid renal tumors in Tsc2+/- mice is duperior to everolimus alone
by: Yang, J, et al.
Published: (2017)

The radiant way : a novel /
by: Drabble, Margaret, 1939-
Published: (1987)

Radiant heating and cooling handbook /
by: 198699 Watson, Richard D., et al.
Published: (2002)

Radiant heating and cooling handbook /
by: 198699 Watson, Richard D., et al.
Published: (2002)

Radiant days : a novel /
by: 444270 Fitzgerald, Michael A.
Published: (2007)

Measurement of radiant heat transfer
by: Farquhar, Norman G, et al.
Published: (2015)

Radiant heat transmission in enclosures
by: Sarofim, Adel F
Published: (2005)

Sandwich theorems for radiant functions
by: Costică Mustăța
Published: (2015-12-01)